Literature DB >> 28055312

The new anticancer era: Tumor metabolism targeting.

Adriana Borriello1, Fulvio Della Ragione1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28055312      PMCID： PMC5324752          DOI： 10.1080/15384101.2016.1271635

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

Review 1.  Serine and one-carbon metabolism in cancer.

Authors:  Ming Yang; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

Review 2.  From Krebs to clinic: glutamine metabolism to cancer therapy.

Authors:  Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Nat Rev Cancer       Date:  2016-07-29       Impact factor: 60.716

3.  Cofactor balance by nicotinamide nucleotide transhydrogenase (NNT) coordinates reductive carboxylation and glucose catabolism in the tricarboxylic acid (TCA) cycle.

Authors:  Paulo A Gameiro; Laura A Laviolette; Joanne K Kelleher; Othon Iliopoulos; Gregory Stephanopoulos
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

4.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

5.  Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.

Authors:  Maria Grazia Cipolleschi; Ilaria Marzi; Roberta Santini; David Fredducci; Maria Cristina Vinci; Massimo D'Amico; Elisabetta Rovida; Theodora Stivarou; Eugenio Torre; Persio Dello Sbarba; Barbara Stecca; Massimo Olivotto
Journal:  Cell Cycle       Date:  2013-11-05       Impact factor: 4.534

6.  High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.

Authors:  Gillian Farnie; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2015-10-13

7.  Low-dose methotrexate enhances cycling of highly anaplastic cancer cells.

Authors:  Maria Grazia Cipolleschi; Ilaria Marzi; Elisabetta Rovida; Massimo Olivotto; Persio Dello Sbarba
Journal:  Cell Cycle       Date:  2016-11-14       Impact factor: 4.534
  7 in total
  6 in total

Review 1.  The wayward methyl group and the cascade to cancer.

Authors:  Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

Review 2.  Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.

Authors:  Ezequiel Monferrer; Isaac Vieco-Martí; Amparo López-Carrasco; Fernando Fariñas; Sergio Abanades; Luis de la Cruz-Merino; Rosa Noguera; Tomás Álvaro Naranjo
Journal:  Metabolites       Date:  2021-04-23

3.  Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition.

Authors:  Farid Ahmad Siddiqui; Gopinath Prakasam; Shilpi Chattopadhyay; Asad Ur Rehman; Rayees Ahmad Padder; Mohammad Afaque Ansari; Rasha Irshad; Kailash Mangalhara; Rameshwar N K Bamezai; Mohammad Husain; Syed Mansoor Ali; Mohammad Askandar Iqbal
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

4.  Oxaloacetate induces apoptosis in HepG2 cells via inhibition of glycolysis.

Authors:  Ye Kuang; Xiaoyun Han; Mu Xu; Qing Yang
Journal:  Cancer Med       Date:  2018-03-13       Impact factor: 4.452

Review 5.  The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer.

Authors:  Yina Yu; Liang Gong; Jun Ye
Journal:  Front Oncol       Date:  2020-06-11       Impact factor: 6.244

6.  Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Authors:  Kei Kawaguchi; Kentaro Igarashi; Shukuan Li; Qinghong Han; Yuying Tan; Tasuku Kiyuna; Kentaro Miyake; Takashi Murakami; Bartosz Chmielowski; Scott D Nelson; Tara A Russell; Sarah M Dry; Yunfeng Li; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Oncotarget       Date:  2017-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.